Redx Pharma PLC (AIM:REDX) said it presented encouraging data at an event in Copenhagen that supported its Porcupine and ROCK inhibitors as potential novel.
/PRNewswire/ Chemomab Therapeutics Ltd. (Nasdaq: CMMB), (Chemomab), a clinical-stage biotechnology company focused on the discovery and development of.